Drug pricing reform deal may allow Medicare to negotiate with drug firms for first time
By
Alicia Lasek
Nov 04, 2021
The Democrats’ deal also would limit insulin costs and cap annual out-of-pocket spending at $2,000 for seniors. Pharmacy benefit managers would face transparency requirements as well.
Medical experts devise list of low-value drugs, prescribing practices
By
Caroline Szachnowski
Feb 22, 2022
Researchers have proposed a new metric for identifying low-value medication prescribing in older adults, according to a recent article in JAMA Network Open.
Cannabis-related issues sending more seniors to the ED, study finds
By
Alicia Lasek
Jan 12, 2023
Cannabis-related ED visits for older adults shot up by a whopping 1,800% between 2005 to 2019 in California, investigators say. The state’s experience mirrors national trends.
‘Snap out of it’: American seniors shy away from depression care despite concerns
By
Alicia Lasek
Nov 17, 2020
Many seniors who reported that they may be depressed during the coronavirus pandemic say they will not seek treatment for their symptoms, a new poll has found.
Mechanotherapy shows success in healing aged muscles, study finds
By
Ron Rajecki
Mar 23, 2023
The combination of mechanotherapy — the use of mechanical forces to stimulate tissue healing — and anti-inflammatory treatment can help heal damage in aged muscles, according to a new study.